Literature DB >> 18197815

Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination.

Zhenming Xu1, Egest J Pone, Ahmed Al-Qahtani, Seok-Rae Park, Hong Zan, Paolo Casali.   

Abstract

Expression and activity of activation-induced cytidine deaminase (AID) encoded by the aicda gene are essential for immunoglobulin (Ig) gene somatic hypermutation (SHM) and class switch DNA recombination (CSR). SHM and CSR unfold, in general, in germinal centers and/are central to the maturation of effective antibody responses. AID expression is induced by activated B-cell CD40 signaling, which is critical for the germinal center reaction, and is further enhanced by other stimuli, including interleukin-4 (IL-4) secreted from CD4+ T cells or Toll-like receptor (TLR)-activating bacterial and/or viral molecules. Integration of different intracellular signal transduction pathways, as activated by these stimuli, leads to a dynamic aicda-regulating program, which involves both positively acting trans-factors, such as Pax5, HoxC4, E47, and Irf8, and negative modulators, such as Blimp1 and Id2, to restrict aicda expression primarily to germinal center B cells. The phosphatidylinositol 3-kinase (PI 3-K), which functions downstream of activated B-cell receptor (BCR) signaling, likely plays an important role in triggering the downregulation of aicda expression in postgerminal center B cells and throughout plasmacytoid differentiation. In B cells undergoing SHM and CSR, AID activity, and, possibly, AID targeting to the Ig locus are regulated at a posttranslational level, including AID dimerization/oligomerization, nuclear/cytoplasmic AID translocation, and phosphorylation of the AID Ser38 residue by protein kinase A (PKA). Here, we discuss the role of B-cell activation signals, transcription regulation programs, and posttranslational modifications in controlling aicda expression and AID activity, thereby delineating an integrated model of modulation of SHM and CSR in the germinal center reaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18197815      PMCID: PMC2994649          DOI: 10.1615/critrevimmunol.v27.i4.60

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  195 in total

1.  Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota.

Authors:  Ahmad Faili; Said Aoufouchi; Eric Flatter; Quentin Guéranger; Claude-Agnès Reynaud; Jean-Claude Weill
Journal:  Nature       Date:  2002-10-31       Impact factor: 49.962

Review 2.  Molecular regulation, evolutionary, and functional adaptations associated with C to U editing of mammalian apolipoproteinB mRNA.

Authors:  Shrikant Anant; Valerie Blanc; Nicholas O Davidson
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2003

3.  The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts.

Authors:  Anu Cherukuri; Tsipi Shoham; Hae Won Sohn; Shoshana Levy; Stephen Brooks; Robert Carter; Susan K Pierce
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

4.  The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.

Authors:  Haifa Jabara; Dhafer Laouini; Erdyni Tsitsikov; Emiko Mizoguchi; Atul Bhan; Emanuela Castigli; Fatma Dedeoglu; Vadim Pivniouk; Scott Brodeur; Raif Geha
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

5.  Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program.

Authors:  A L Shaffer; Kuo I Lin; Tracy C Kuo; Xin Yu; Elaine M Hurt; Andreas Rosenwald; Jena M Giltnane; Liming Yang; Hong Zhao; Kathryn Calame; Louis M Staudt
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

6.  DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL.

Authors:  Mikhail B Litinskiy; Bernardetta Nardelli; David M Hilbert; Bing He; Andras Schaffer; Paolo Casali; Andrea Cerutti
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

7.  Transcription-coupled events associating with immunoglobulin switch region chromatin.

Authors:  Yukiko Nambu; Manabu Sugai; Hiroyuki Gonda; Chung-Gi Lee; Tomoya Katakai; Yasutoshi Agata; Yoshifumi Yokota; Akira Shimizu
Journal:  Science       Date:  2003-12-19       Impact factor: 47.728

8.  CD40 stimulation induces Pax5/BSAP and EBF activation through a APE/Ref-1-dependent redox mechanism.

Authors:  Sonia Merluzzi; Massimo Moretti; Sandro Altamura; Patty Zwollo; Mikael Sigvardsson; Gaetano Vitale; Carlo Pucillo
Journal:  J Biol Chem       Date:  2003-10-31       Impact factor: 5.157

9.  AID mutant analyses indicate requirement for class-switch-specific cofactors.

Authors:  Van-Thanh Ta; Hitoshi Nagaoka; Nadia Catalan; Anne Durandy; Alain Fischer; Kohsuke Imai; Shigeaki Nonoyama; Junko Tashiro; Masaya Ikegawa; Satomi Ito; Kazuo Kinoshita; Masamichi Muramatsu; Tasuku Honjo
Journal:  Nat Immunol       Date:  2003-08-10       Impact factor: 25.606

10.  The balance between Pax5 and Id2 activities is the key to AID gene expression.

Authors:  Hiroyuki Gonda; Manabu Sugai; Yukiko Nambu; Tomoya Katakai; Yasutoshi Agata; Kazuhiro J Mori; Yoshifumi Yokota; Akira Shimizu
Journal:  J Exp Med       Date:  2003-10-27       Impact factor: 14.307

View more
  47 in total

Review 1.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 2.  Immunoglobulin class-switch DNA recombination: induction, targeting and beyond.

Authors:  Zhenming Xu; Hong Zan; Egest J Pone; Thach Mai; Paolo Casali
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

Review 3.  Activation-induced cytidine deaminase and aberrant germinal center selection in the development of humoral autoimmunities.

Authors:  Ahmad Zaheen; Alberto Martin
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 4.  Toll-like receptors and cancer.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Nat Rev Cancer       Date:  2008-12-04       Impact factor: 60.716

5.  MicroRNA 155 control of p53 activity is context dependent and mediated by Aicda and Socs1.

Authors:  Hakim Bouamar; Daifeng Jiang; Long Wang; An-Ping Lin; Manoela Ortega; Ricardo C T Aguiar
Journal:  Mol Cell Biol       Date:  2015-02-02       Impact factor: 4.272

6.  Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Authors:  Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

Review 7.  Augmentation of antibody responses by retinoic acid and costimulatory molecules.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Semin Immunol       Date:  2008-09-25       Impact factor: 11.130

Review 8.  Could retinoids be a potential treatment for rheumatic diseases?

Authors:  Yoshishige Miyabe; Chie Miyabe; Toshihiro Nanki
Journal:  Rheumatol Int       Date:  2014-06-18       Impact factor: 2.631

9.  Multiple clonal MLL fusions in a patient receiving CHOP-based chemotherapy.

Authors:  Shyh-Jen Shih; Joseph Fass; Vincent Buffalo; Dawei Lin; Sheetal P Singh; Manuel O Diaz; Andrew T Vaughan
Journal:  Br J Haematol       Date:  2012-07-30       Impact factor: 6.998

10.  HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation.

Authors:  Seok-Rae Park; Hong Zan; Zsuzsanna Pal; Jinsong Zhang; Ahmed Al-Qahtani; Egest J Pone; Zhenming Xu; Thach Mai; Paolo Casali
Journal:  Nat Immunol       Date:  2009-04-12       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.